National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Adult Brain Tumors Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 01/02/2009



Purpose of This PDQ Summary






General Information






Classification






Treatment Option Overview






Brain Stem Gliomas






Pineal Astrocytic Tumors






Pilocytic Astrocytomas






Diffuse Astrocytomas






Anaplastic Astrocytomas






Glioblastoma






Oligodendroglial Tumors






Mixed Gliomas






Ependymal Tumors






Embryonal Cell Tumors: Medulloblastoma






Pineal Parenchymal Tumors






Meningeal Tumors






Germ Cell Tumors






Tumors of the Sellar Region: Craniopharyngioma






Recurrent Brain Tumors






Metastatic Brain Tumors






Get More Information From NCI






Changes to This Summary (01/02/2009)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Brain Stem Gliomas

Current Clinical Trials

Brain stem gliomas have relatively poor prognoses that correlate with histology (when biopsies are performed), location, and extent of tumor. The overall median survival time of patients in studies has been 44 to 74 weeks.[1-5] The best results have been attained with hyperfractionated radiation therapy.[5]

Standard treatment options:

  • Radiation therapy.[1-6]

Treatment options under clinical evaluation:

  • At recurrence, patients should be considered for clinical trials that evaluate new drugs and biological response modifiers.[7,8]
Current Clinical Trials

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with adult brain stem glioma. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site.

References

  1. Greenberger JS, Cassady JR, Levene MB: Radiation therapy of thalamic, midbrain and brain stem gliomas. Radiology 122 (2): 463-8, 1977.  [PUBMED Abstract]

  2. Levin VA, Edwards MS, Wara WM, et al.: 5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Childrens Cancer Group. Neurosurgery 14 (6): 679-81, 1984.  [PUBMED Abstract]

  3. Allen JC, Bloom J, Ertel I, et al.: Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease. Semin Oncol 13 (1): 110-22, 1986.  [PUBMED Abstract]

  4. Eifel PJ, Cassady JR, Belli JA: Radiation therapy of tumors of the brainstem and midbrain in children: experience of the Joint Center for Radiation Therapy and Children's Hospital Medical Center (1971-1981). Int J Radiat Oncol Biol Phys 13 (6): 847-52, 1987.  [PUBMED Abstract]

  5. Shrieve DC, Wara WM, Edwards MS, et al.: Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults. Int J Radiat Oncol Biol Phys 24 (4): 599-610, 1992.  [PUBMED Abstract]

  6. Surma-aho O, Niemelä M, Vilkki J, et al.: Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56 (10): 1285-90, 2001.  [PUBMED Abstract]

  7. Fulton DS, Levin VA, Wara WM, et al.: Chemotherapy of pediatric brain-stem tumors. J Neurosurg 54 (6): 721-5, 1981.  [PUBMED Abstract]

  8. Rodriguez LA, Prados M, Fulton D, et al.: Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil, CCNU, hydroxyurea, and 6-mercaptopurine. Neurosurgery 22 (4): 691-3, 1988.  [PUBMED Abstract]

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov